The Annual Meeting of the global organization Health Technology Assessment international HTAi was held on June 24-28, 2023. Due to its global activities, the organization's strategy is to organize conferences every other year on different continents. This year's conference took place in in Adelaide, Australia with the active participation of Dr. Iga Lipska, Chairwoman of

At the invitation of the Embassy of the United Kingdom of Great Britain and Northern Ireland in Warsaw, representatives of the Management Board of the Health Policy Institute Poland took part in the official celebrations of the birthday of King Charles III: Iga Lipska – Chairwoman and Łukasz Więch – Vice-President of the Board. We

EHMA 2023 is behind us! On June 5-7, we had the pleasure to represent Poland at the annual conference of the European Health Management Association EHMA in Rome, Italy. The theme of the conference was the management of health systems and proposals for sustainable solutions for complex systems. At the invitation of EHMA, dr. Iga

The conference “How to assess the value of artificial intelligence in health care?” took place at the Kozminski University, in cooperation with the Supreme Medical Chamber (Central Research and Education Center) and Domaniewski Zakrzewski Palinka Law Firm, under the auspices of the Committee on Digitization, Innovation and Modern Technologies of the Polish Parliament. This is

Are we prepared to implement HTA Regulation? In particular in Central Eastern European jurisdictions? EU HTA Regulation came into force in Jan 2022 and will apply from Jan 2025 for oncology drugs and ATMPs (Advanced Therapy Medicinal Products). Iga Lipska the Chairwoman of Health Policy Institute Board presented this important topic at Czech ISPOR chapter. A lot of

International cooperation in scientific and research projects is of crucial importance for us. That is why we actively participate at the Information Day on the EU4HEALTH program organized by the Ministry of Health. We listen to all participants and share our experience, including our expert experience in the evaluation of applications in the EU HORIZON

It was out great pleasure and honour to participate in the educational workshop on foreseen legislative changes in EU Pharmaceutical legislation. The timing of the event titled: How Europe can defeat rare diseases? The upcoming amendment to the OMP regulations as an opportunity for European society was perfect – just before the release of draft